Recent Quotes
My Watchlist
Indicators
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

138.54 +0.67 (+0.49%)
Official Closing Price Updated: 7:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,039,777
Open 138.28
Bid (Size) 136.89 (100)
Ask (Size) 140.01 (100)
Prev. Close 137.87
Today's Range 137.02 - 138.56
52wk Range 96.91 - 140.18
Shares Outstanding N/A
Dividend Yield 2.88%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The RNAi Powerhouse: A Deep Dive into Alnylam Pharmaceuticals’ Path to the S&P 500
As the calendar turns to 2026, Alnylam Pharmaceuticals (Nasdaq: ALNY) stands at the threshold of a new era. Once a speculative pioneer in the arcane world of RNA interference (RNAi), the... 
Via PredictStreet
Topics Economy Intellectual Property Stocks
News headline image
The $3 Billion Bet: How Isomorphic Labs is Rewriting the Rules of Drug Discovery with Eli Lilly and Novartis
In a move that has fundamentally reshaped the landscape of the pharmaceutical industry, Isomorphic Labs—the London-based drug discovery arm of Alphabet Inc. (NASDAQ: GOOGL)—has solidified its position... 
Via TokenRing AI
Topics Artificial Intelligence

Performance

YTD
N/A
N/A
1 Month
+3.6%
+3.6%
3 Month
+4.6%
+4.6%
6 Month
+13.4%
+13.4%
1 Year
+42.6%
+42.6%

More News

Read More
Novartis AG (NYSE:NVS) Stands Out as a Dependable Dividend Stock with Strong Fundamentals ↗
Via Chartmill
News headline image
The Great Unlocking: How AlphaFold 3’s Open-Source Pivot Sparked a New Era of Drug Discovery
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Decoding Life’s Blueprint: How AlphaFold 3 is Redefining the Frontier of Medicine
Via TokenRing AI
Topics Artificial Intelligence Bonds
News headline image
Invest Outside the U.S. With These Top International ETFs ↗
Via The Motley Fool
Topics ETFs
News headline image
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Pfizer Leads New Wave Of 2026 US Drug Price Hikes Despite Trump’s Drug Cost Crackdown: Report ↗
Via Stocktwits
Topics Economy Government
News headline image
The “Operating System of Life”: How AlphaFold 3 Redefined Biology and the Drug Discovery Frontier
Via TokenRing AI
Topics Artificial Intelligence
News headline image
AlphaFold’s Five-Year Reign: 3 Million Researchers and the Dawn of a New Biological Era
Via TokenRing AI
Topics Artificial Intelligence Climate Change
News headline image
Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
Via MarketMinute
Topics ETFs Intellectual Property
News headline image
Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Compelling Value Investment Case ↗
Via Chartmill
News headline image
The Biological Turing Point: How AlphaFold 3 and the Nobel Prize Redefined the Future of Medicine
Via TokenRing AI
Topics Artificial Intelligence Initial Public Offering
News headline image
Stock Market Today, Dec. 23: Novo Nordisk Surges After FDA Approves Oral Wegovy Weight Loss Pill ↗
Via The Motley Fool
Topics Stocks
News headline image
The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
2 Top Stocks to Buy and Hold for the Long Term ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants ↗
Via Stocktwits
Topics Government World Trade
News headline image
Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump ↗
Via Investor's Business Daily
Topics Government Stocks
News headline image
AbbVie, Merck, Other Top Drugmakers To Lower Prices Of US Drugs In MFN Deal With Trump Administration: Report ↗
Via Stocktwits
Topics Economy Government
News headline image
White House Readies Drug Price Deals With AbbVie, Novartis, Roche ↗
Via Benzinga
News headline image
Salesforce Stock Rises On BTIG Buy Rating And Novartis Agentforce Deal ↗
Via Benzinga
News headline image
Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks ↗
Via Stocktwits
Topics Government World Trade
News headline image
Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock with Strong Financials ↗
Via Chartmill
News headline image
Novartis' Investigational Drug Reports Longer Disease Control In Patients With Rare Blood Disorder ↗
Via Benzinga
News headline image
Silver Shines as Global Tariff Storm Gathers: A Safe-Haven and Strategic Imperative in 2025
Via MarketMinute
Topics Artificial Intelligence Economy Energy

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 138.54
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 01/02/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>